RediNews
ETFs Holding GERN »    GERN Historical Stock Prices »
GERN News Video: Thu, Apr 12, 2018, 1:38 PM — Thursday Sector Leaders: Biotechnology, Railroads


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Geron supports the clinical stage development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies, by Janssen Biotech, Inc. (Janssen). Co. has a collaboration and license agreement pursuant to which it granted Janssen the rights to develop and commercialize imetelstat worldwide for all indications in oncology, including hematologic myeloid malignancies, and all other human therapeutic uses. In addition, Co. has granted a license to Janssen Pharmaceuticals, Inc. for the research, development and commercialization of products based on oligonucleotide backbone chemistry and amidates for disorders, excluding cancers originating from the blood or bone marrow. Self directed investors in Geron Corp. will be interested in keeping up with all Geron Corp. news they can find, both GERN news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on GERN. At RediNews, we simplify this task by presenting both GERN news releases originating from Geron Corp. itself, and GERN news from a variety of media outlets. Visitors can browse this news online and through our GERN RSS news feed.

GERN News

GERN News — Articles, Videos, & Press Releases

July 5th Options Now Available For Geron (GERN)
Thursday, May 23, 2019, 10:57 AM — Stock Options Channel
Interesting GERN Put Options For July 19th
Thursday, May 23, 2019, 10:34 AM — Stock Options Channel
Notable Wednesday Option Activity: DOX, GERN, ADBE
Wednesday, May 15, 2019, 3:39 PM — Stock Options Channel
Why Is Geron (GERN) Up 27.3% Since Last Earnings Report?
Saturday, April 6, 2019, 7:30 AM — Zacks
Geron's (GERN) Q4 Loss In Line, Revenues Beat, Stock Up
Friday, March 8, 2019, 9:10 AM — Zacks
April 12th Options Now Available For Geron (GERN)
Thursday, February 28, 2019, 10:59 AM — Stock Options Channel
GERN March 29th Options Begin Trading
Thursday, February 7, 2019, 11:11 AM — Stock Options Channel
March 1st Options Now Available For Geron
Thursday, January 10, 2019, 11:14 AM — Stock Options Channel
GERN February 22nd Options Begin Trading
Thursday, January 3, 2019, 12:17 PM — Stock Options Channel
Interesting GERN Put Options For February 15th
Thursday, January 3, 2019, 11:21 AM — Stock Options Channel
GERN January 2019 Options Begin Trading
Wednesday, November 21, 2018, 11:40 AM — Stock Options Channel
GERN December 14th Options Begin Trading
Thursday, November 1, 2018, 11:39 AM — Stock Options Channel
GERN December 14th Options Begin Trading
Thursday, November 1, 2018, 11:38 AM — Stock Options Channel
First Week of June 2019 Options Trading For Geron (GERN)
Wednesday, October 24, 2018, 1:23 PM — Stock Options Channel
Surprising Analyst 12-Month Target For IEIH
Friday, September 28, 2018, 9:07 AM — ETF Channel
Interesting GERN Put And Call Options For November 9th
Thursday, September 27, 2018, 11:16 AM — Stock Options Channel
First Week of November 16th Options Trading For Geron (GERN)
Wednesday, September 26, 2018, 10:47 AM — Stock Options Channel
First Week of January 2021 Options Trading For Geron
Tuesday, September 18, 2018, 11:07 AM — Stock Options Channel
Noteworthy Tuesday Option Activity: TXN, GERN, V
Tuesday, September 11, 2018, 3:18 PM — Stock Options Channel
Noteworthy Monday Option Activity: GERN, FIT, FTV
Monday, August 27, 2018, 3:25 PM — Stock Options Channel
Noteworthy Friday Option Activity: XLRN, GERN, CAL
Friday, August 17, 2018, 3:20 PM — Stock Options Channel
First Week of GERN March 2019 Options Trading
Tuesday, July 24, 2018, 12:28 PM — Stock Options Channel
Notable Friday Option Activity: FIVE, GERN, LLNW
Friday, July 20, 2018, 3:37 PM — Stock Options Channel
Analysts See 37% Gains Ahead For XBI
Thursday, July 19, 2018, 7:48 AM — ETF Channel
Short Interest Makes 18.2% Move For GERN
Thursday, July 12, 2018, 10:51 AM — Market News Video
Interesting GERN Put And Call Options For October 19th
Tuesday, July 10, 2018, 10:43 AM — Stock Options Channel
Interesting GERN Put And Call Options For August 17th
Wednesday, June 20, 2018, 11:41 AM — Stock Options Channel
Notable Friday Option Activity: XOM, GERN, PFE
Friday, June 15, 2018, 3:19 PM — Stock Options Channel
GERN is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

ALNY News
PACB News
ZLTQ News
HNSN News
CADX News
CNDO News
VSTM News
AGEN News
TEAR News
ACAD News

Whether you use an enterprise information portal to update a corporate relations page, or have a handmade website with investor content in it, chances are you have come across the term "RSS" — Really Simple Syndication. Web page finance website experts and novices alike are welcome to integrate any of the RediNews RSS feeds found on the stock market content pages within our website. Simply navigate to any RediNews news page by specific ticker symbol, then click the RSS icon for any news page to reach the associated RSS feed (the icon will look like this): . Our news would be ideal paired with free stock chart and investor content, querying for the same specific stock ticker symbol presented to the user. While experience with flash and cobranded content would be ideal for integrating our news in a cool and unique way such as within a stock market ticker or stock screener feature, our feeds can also be integrated as extra links to enhance your financial portal content with dynamic stock content that updates every time there is new news tagged with the stock, giving your visitors another reason to check back to your website in the future.

GERN News | www.RediNews.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.